|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,738 INR | +3.87% |
|
+2.65% | +19.12% |
| 05-10 | Transcript : Hester Biosciences Limited, Q4 2024 Earnings Call, May 10, 2024 | |
| 05-10 | Hester Biosciences' Consolidated Net Profit Rises in Fiscal Q4; Shares Jump 4% | MT |
Hester Biosciences Limited reported earnings results for the nine months ended December 31, 2022. For the nine months, the company reported sales was INR 1,785.37 million. Revenue was INR 1,850.86 million.
Net income was INR 315.97 million. Basic earnings per share from continuing operations was INR 35.83. Diluted earnings per share from continuing operations was INR 35.83.
| 1st Jan change | Capi. | |
|---|---|---|
| +19.12% | 177M | |
| -14.35% | 77.13B | |
| +14.09% | 8.4B | |
| +27.62% | 3.79B | |
| -0.70% | 3.22B | |
| +14.70% | 1.64B | |
| -10.12% | 1.5B | |
| -22.60% | 1.3B | |
| -4.20% | 1.25B | |
| -10.26% | 1.18B |
HESTER BIOSCIENCES LIMITED 